In France, healthcare researcher Cegedim Strategic Data (CSD) has expanded its patient and medical research to provide longitudinal patient data in France, Germany, Italy, Spain and the UK.
The firm offers a wide range of analyses based on real-life observational patient data to help pharmaceutical firms manage portfolio lifecycle challenges and future opportunities. Examples include market share in Rx and patients, prescriptions and co-prescriptions, patient profiles, and dynamic segments.
CEO Bruno Sarfati stated: 'With this strengthening of our offer, CSD creates more value for its clients and will continue to extend these offers in the future.'
CSD's Medical Research department conducts pharmaco-epidemiological studies, disease prevalence, risk management, health economics and outcome studies.
The company already has longitudinal patient databases in Australia, Belgium, Czech Republic, and Korea.
Last month, CSD launched a service which integrates its various data sources and deliver comprehensive analysis.
Web site: www.cegedimstrategicdata.com .
All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.
Register (free) for Daily Research News
REGISTER FOR NEWS EMAILS
To receive (free) news headlines by email, please register online